CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Fresenius Kabi USA, LLC recalls Famotidine Injection

Read the official FDA notice

Published
3 Dec 2025
Units affected
2,199,850 vials
Agency
FDA
Country
United States

The hazard

Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.

Classification: Class I — the most serious type: there is a reasonable chance this product could cause serious health problems or death.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL vials, Rx only, Fresenius Kabi USA, LLC, NDC 63323-739-11 (unit of use), 63323-739-12 (unit of sale).

Brand / company
Fresenius Kabi USA, LLC
Codes / lots
Lot #: 6133156, 6133194, Exp Date: 08/2026; 6133388, Exp Date: 10/2026.
Distribution
Nationwide within the United States as well as AK, HI, and PR.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 3 Dec 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.